We are live on
!
Find out more
Kymera Therapeutics
KYMR
KYMR
180 hedge funds and large institutions have $2.89B invested in Kymera Therapeutics in 2024 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 60 increasing their positions, 60 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
326% more call options, than puts
Call options by funds: $3M | Put options by funds: $704K
29% more funds holding in top 10
Funds holding in top 10: 7 → 9 (+2)
18% more first-time investments, than exits
New positions opened: 33 | Existing positions closed: 28
2.43% more ownership
Funds ownership: 108.3% → 110.73% (+2.4%)
2% more funds holding
Funds holding: 176 → 180 (+4)
0% more repeat investments, than reductions
Existing positions increased: 60 | Existing positions reduced: 60
12% less capital invested
Capital invested by funds: $3.27B → $2.89B (-$383M)
Holders
180
Holders Change
+4
Holders Change %
+2.27%
% of All Funds
2.37%
Holding in Top 10
9
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+28.57%
% of All Funds
0.12%
New
33
Increased
60
Reduced
60
Closed
28
Calls
$3M
Puts
$704K
Net Calls
+$2.29M
Net Calls Change
+$3.36M
Top Buyers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$31.1M |
| 2 |
ACA
Avoro Capital Advisors
New York
|
+$29.4M |
| 3 |
DM
Deerfield Management
New York
|
+$26.8M |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$16.4M |
| 5 |
EC
EcoR1 Capital
San Francisco,
California
|
+$15.8M |
Top Sellers
| 1 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$28.4M |
| 2 |
RG
Redmile Group
San Francisco,
California
|
-$13.2M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$12.6M |
| 4 |
Morgan Stanley
New York
|
-$11.2M |
| 5 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
-$10.9M |
